16-725464-C-A
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001378030.1(CCDC78):c.384G>T(p.Glu128Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000321 in 1,612,778 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. E128E) has been classified as Likely benign.
Frequency
Consequence
NM_001378030.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCDC78 | NM_001378030.1 | c.384G>T | p.Glu128Asp | missense_variant | 4/14 | ENST00000345165.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCDC78 | ENST00000345165.10 | c.384G>T | p.Glu128Asp | missense_variant | 4/14 | 5 | NM_001378030.1 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00165 AC: 251AN: 152236Hom.: 1 Cov.: 34
GnomAD3 exomes AF: 0.000497 AC: 124AN: 249610Hom.: 0 AF XY: 0.000325 AC XY: 44AN XY: 135464
GnomAD4 exome AF: 0.000182 AC: 266AN: 1460424Hom.: 0 Cov.: 37 AF XY: 0.000172 AC XY: 125AN XY: 726494
GnomAD4 genome AF: 0.00165 AC: 252AN: 152354Hom.: 1 Cov.: 34 AF XY: 0.00162 AC XY: 121AN XY: 74504
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Oct 31, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 28, 2020 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 01, 2024 | The c.384G>T (p.E128D) alteration is located in exon 4 (coding exon 4) of the CCDC78 gene. This alteration results from a G to T substitution at nucleotide position 384, causing the glutamic acid (E) at amino acid position 128 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Congenital myopathy with internal nuclei and atypical cores Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
CCDC78-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 22, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at